The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Niels P. Riksen

Department of Pharmacology-Toxicology

Radboud University Nijmegen Medical Centre

P, O, Box 9101

Nijmegen

Netherlands

[email]@aig.umcn.nl

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Pharmacology-Toxicology, Radboud University Nijmegen Medical Centre, P, O, Box 9101, Nijmegen, Netherlands. 2003 - 2012

References

  1. Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study. Engbersen, R., Riksen, N.P., Mol, M.J., Bravenboer, B., Boerman, O.C., Meijer, P., Oyen, W.J., Tack, C., Rongen, G.A., Smits, P. Cardiovasc. Diabetol (2012) [Pubmed]
  2. The cardiovascular effects of methylxanthines. Riksen, N.P., Smits, P., Rongen, G.A. Handb. Exp. Pharmacol (2011) [Pubmed]
  3. Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease. Riksen, N.P., Rongen, G.A., Smits, P. Pharmacol. Ther. (2009) [Pubmed]
  4. Human in vivo research on the vascular effects of adenosine. Riksen, N.P., Rongen, G.A., Yellon, D., Smits, P. Eur. J. Pharmacol. (2008) [Pubmed]
  5. Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34C > T variant of the AMPD1 gene. Riksen, N.P., Franke, B., Oyen, W.J., Borm, G.F., van den Broek, P., Boerman, O.C., Smits, P., Rongen, G.A. Eur. Heart J. (2007) [Pubmed]
  6. Antibodies against the CUB1-2 domains of ADAMTS13 in a patient with benign monoclonal gammopathy: no causal relationship. Riksen, N.P., Luken, B.M., Klasen, I.S., Voorberg, J., Crama, N., van Deuren, M. Haematologica (2007) [Pubmed]
  7. Acute elevation of plasma non-esterified fatty acids increases pulse wave velocity and induces peripheral vasodilation in humans in vivo. Riksen, N.P., Bosselaar, M., Bakker, S.J., Heine, R.J., Rongen, G.A., Tack, C.J., Smits, P. Clin. Sci. (2007) [Pubmed]
  8. The 1976C>T polymorphism in the adenosine A2A receptor gene does not affect the vasodilator response to adenosine in humans in vivo. Riksen, N.P., Franke, B., van den Broek, P., Smits, P., Rongen, G.A. Pharmacogenet. Genomics (2007) [Pubmed]
  9. Methotrexate modulates the kinetics of adenosine in humans in vivo. Riksen, N.P., Barrera, P., van den Broek, P.H., van Riel, P.L., Smits, P., Rongen, G.A. Ann. Rheum. Dis. (2006) [Pubmed]
  10. Caffeine prevents protection in two human models of ischemic preconditioning. Riksen, N.P., Zhou, Z., Oyen, W.J., Jaspers, R., Ramakers, B.P., Brouwer, R.M., Boerman, O.C., Steinmetz, N., Smits, P., Rongen, G.A. J. Am. Coll. Cardiol. (2006) [Pubmed]
  11. Enhanced cellular adenosine uptake limits adenosine receptor stimulation in patients with hyperhomocysteinemia. Riksen, N.P., Rongen, G.A., Boers, G.H., Blom, H.J., van den Broek, P.H., Smits, P. Arterioscler. Thromb. Vasc. Biol. (2005) [Pubmed]
  12. In vivo evidence against a role for adenosine in the exercise pressor reflex in humans. Riksen, N.P., van Ginneken, E.E., van den Broek, P.H., Smits, P., Rongen, G.A. J. Appl. Physiol. (2005) [Pubmed]
  13. Oral therapy with dipyridamole limits ischemia-reperfusion injury in humans. Riksen, N.P., Oyen, W.J., Ramakers, B.P., Van den Broek, P.H., Engbersen, R., Boerman, O.C., Smits, P., Rongen, G.A. Clin. Pharmacol. Ther. (2005) [Pubmed]
  14. Reduced adenosine receptor stimulation as a pathogenic factor in hyperhomocysteinemia. Riksen, N.P., Rongen, G.A., Blom, H.J., Boers, G.H., Smits, P. Clin. Chem. Lab. Med. (2005) [Pubmed]
  15. Ischaemic preconditioning: from molecular characterisation to clinical application--part I. Riksen, N.P., Smits, P., Rongen, G.A. Neth. J. Med (2004) [Pubmed]
  16. Ischaemic preconditioning: from molecular characterisation to clinical application--part II. Riksen, N.P., Smits, P., Rongen, G.A. Neth. J. Med (2004) [Pubmed]
  17. Rituximab in the treatment of relapsing idiopathic thrombocytopenic purpura. Riksen, N.P., Keuning, J.J., Vreugdenhil, G. Neth. J. Med (2003) [Pubmed]
 
WikiGenes - Universities